Skip to main content
Edwards Lifesciences Logo
Edwards Lifesciences Logo

The INSPIRIS RESILIA aortic valve

Helpful resources.

man with glasses in black and white
man with glasses in black and white
man with glasses in black and white

Managing aortic stenosis

Additional support for the INSPIRIS RESILIA aortic valve

INSPIRIS RESILIA aortic valve brochure
INSPIRIS RESILIA aortic valve brochure
INSPIRIS RESILIA aortic valve brochure

INSPIRIS RESILIA aortic valve brochure

Download
COMMENCE 7-year clinical summary
COMMENCE 7-year clinical summary
COMMENCE 7-year clinical summary

COMMENCE trial 7-year clinical summary

Download
COMMENCE 5-year clinical summary
COMMENCE 5-year clinical summary
COMMENCE 5-year clinical summary

COMMENCE trial 5-year clinical summary

Download

Look closer at patients who could benefit from the INSPIRIS RESILIA aortic valve

Look closer
inspiris home banner image thumb
inspiris home banner image thumb
inspiris home banner image thumb

No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue. 

Refer to device instructions for use for important warnings related to VFit technology. These features have not been observed in clinical studies to establish the safety and effectiveness of the model 11500A for use in valve-in-valve procedures. VFit technology is available on sizes 19–25 mm.

Medical device for professional use

Medical device for professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).